Wellington Management Group
AGN

Wellington Management Group’s Allergan plc AGN Stock Holding History

Wellington Management Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-325
Closed -$426K – 2388
2017
Q4 		$426K Buy
325
+185
+132% +$33.2K ﹤0.01% 2076
2017
Q3 		$213K Buy
140
+10
+8% +$2.33K ﹤0.01% 2164
2017
Q2 		$301K Buy
+130
New +$30.5K ﹤0.01% 2111

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Wellington Management Group's AGN Position: Q2 2020 in Review

Wellington Management Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 779,559 shares — an estimated $138M sold.

Wellington Management Group first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $6.65B in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Wellington Management Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Wellington Management Group sold 779,559 Allergan plc shares in Q2 2020, an estimated $138M.
  • Wellington Management Group first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Wellington Management Group's Allergan plc position peaked at $6.65B in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Wellington Management Group's 13F filing for Q2 2020, filed 14 Aug 2020.